Literature DB >> 26837490

Conundrums and Caveats in Neuroendocrine Tumors of the Pancreas.

Laura H Tang1, David S Klimstra2.   

Abstract

Pancreatic neuroendocrine tumors (Pan-NETs) are the second most common epithelial neoplasm of the pancreas after ductal adenocarcinoma. They can be clinically defined as functional, nonfunctional, and hereditary. This review addresses typical and atypical pathologic features of Pan-NETs, with a focus on practical issues involved in differential diagnosis, immunohistochemical work-up, intraoperative frozen section interpretation, sources of diagnostic errors, and classification. The diagnosis of a Pan-NET requires analysis of all available clinical and radiographic information and pathologic characteristics of the tumor, and it is crucial to understand the clinical impact of the pathologic interpretation.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Chromogranin; Endocrine; Islet cell tumor; Ki 67; Neuroendocrine; Neuroendocrine neoplasm; Neuroendocrine tumor; Pancreas; Somatostatin receptor

Year:  2011        PMID: 26837490     DOI: 10.1016/j.path.2011.03.003

Source DB:  PubMed          Journal:  Surg Pathol Clin        ISSN: 1875-9157


  1 in total

1.  ATRX, DAXX or MEN1 mutant pancreatic neuroendocrine tumors are a distinct alpha-cell signature subgroup.

Authors:  Chang S Chan; Saurabh V Laddha; Peter W Lewis; Matthew S Koletsky; Kenneth Robzyk; Edaise Da Silva; Paula J Torres; Brian R Untch; Janet Li; Promita Bose; Timothy A Chan; David S Klimstra; C David Allis; Laura H Tang
Journal:  Nat Commun       Date:  2018-10-12       Impact factor: 14.919

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.